Dr Kristi Kuper Joins DoseMe as Director of Clinical Pharmacy

World News: . []

MOORESTOWN, N.J., Sept. 11, 2019 (GLOBE NEWSWIRE) -- (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced pharmacy executive Dr Kristi Kuper joins subsidiary DoseMe as Director of Clinical Pharmacy.

Dr. Kuper is a Board Certified Pharmacotherapy Specialist who has spent the last 20 years in a variety of clinical pharmacy leadership roles working with more than 500 hospitals. She has contributed to over 40 publications and has experience co-leading national research projects on under-researched areas in antibiotic stewardship. She is a recognized expert in the use of clinical decision support to improve medication utilization in the acute care setting.

“DoseMe and the Tabula Rasa HealthCare group are leading the way in how we combine technology and innovation to better refine the use of medications,” said Kuper. “I’m excited to be part of a large and established team of researchers, clinicians, and informatics professionals who are focused on bringing precision medicine to the bedside in a scalable and efficient manner.”

At DoseMe, Dr. Kuper will work closely with health systems as she continues to grow the body of literature on precision dosing and lead DoseMe’s Clinical Advisory Board.

“Kristi is passionate and understands medication safety and antimicrobial stewardship in the acute care setting, in a way few executives can hope to,” said Charles Cornish, CEO of DoseMe. “She’s joining an already successful, energetic team at the perfect time to expand our clinical focus.”

“We are honored to have another experienced clinical pharmacist join the Tabula Rasa HealthCare team,” said TRHC Chairman and CEO Calvin H. Knowlton, PhD. “Kristi’s experience is crucial as we continue to expand our solutions throughout the acute care and outpatient treatment settings both in the United States and internationally.”

Dr. Kuper has served on a number of committees, including the Center for Disease Control (CDC) and Pew Charitable Trust workgroups on antibiotic stewardship, the National Quality Forum’s Antibiotic Stewardship “Playbook” and was an invited attendee at the White House Forum on Antibiotic Stewardship. She currently serves as a technical advisor for the AHRQ Safety Program for Improving Antibiotic Use, is Chair of the Society of Infectious Diseases Pharmacist's Policy and Government Affairs Committee and is a tenured member of the City of Houston Antibiotic Stewardship Executive Committee.

Dr. Kuper received her Doctor of Pharmacy from the University of Nebraska Medical Center and completed a pharmacy practice residency at the James A Haley Veterans Hospital in Tampa, Florida. She currently resides in Houston, Texas.

More news and information about Tabula Rasa Healthcare, Inc.

Published By:

Globe Newswire: 13:00 GMT Wednesday 11th September 2019

Published: .

Search for other references to "kristi" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us